SEPN
Septerna, Inc.
NASDAQ · USHealthcareBiotechnology
$32.21-3.56%
Price as of Jul 20, 2026
SEPN valuation
Septerna, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 36.76x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.84x
- Price / sales
- 20.09x
- Price / cash flow
- 13.46x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 15.61x
- EV / EBITDA
- -21.63x
- EV / EBIT
- -20.25x
- Market cap
- $1.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.